Both in Pharmaceuticals
Kailera Therapeutics vs uniQure
Over the past year KLRA returned −9.8% and QURE returned −46.4%; their daily moves had a correlation of 0.26.
KLRA −9.8% QURE −46.4%Growth of $1, one year, split-adjusted
| Metric | KLRA | QURE |
|---|---|---|
| Price | $12.58 | $23.87 |
| Market cap | $1.63B | $1.66B |
| Today | +3.54% | +3.92% |
| 1 month | +16.1% | +4.7% |
| 6 months | — | +12.8% |
| Year to date | — | −0.3% |
| 1 year | — | −64.7% |
| Revenue growth (YoY) | — | +11.0% |
| Gross margin | — | 94.0% |
| Net margin | — | −1387.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 88.7× |
| Net cash | $916.7M | $760.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 109.1% |
| Short % of float | 9.1% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).